{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:16:41Z","timestamp":1774869401226,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1993,7,1]],"date-time":"1993-07-01T00:00:00Z","timestamp":741484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1993,7]]},"DOI":"10.1007\/bf02253531","type":"journal-article","created":{"date-parts":[[2005,11,22]],"date-time":"2005-11-22T21:48:21Z","timestamp":1132696101000},"page":"423-426","source":"Crossref","is-referenced-by-count":43,"title":["Involvement of \u03b4-opioid receptors in the effects of morphine on locomotor activity and the mesolimbic dopaminergic system in mice"],"prefix":"10.1007","volume":"111","author":[{"given":"Minoru","family":"Narita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Funada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwa","family":"Misawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02253531_CR1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0006-8993(87)91327-8","volume":"414","author":"MA Bozarth","year":"1987","unstructured":"Bozarth MA (1987) Neuroanatomical boundaries of the reward-relevant opiate-receptor field in the ventral tegmental area as mapped by the conditioned place preference method in rats. Brain Res 414:77\u201384","journal-title":"Brain Res"},{"key":"BF02253531_CR2","first-page":"1067","volume":"244","author":"G Chiara Di","year":"1988","unstructured":"Di Chiara G, Imperato A (1988) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244:1067\u20131080","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02253531_CR3","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0091-3057(81)90056-3","volume":"15","author":"M Hirabayashi","year":"1981","unstructured":"Hirabayashi M, Alam MR (1981) Enhancement effect of methamphetamine on ambulatory activity produced by repeated administration in mice. Pharmacol Biochem Behav 15:925\u2013932","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02253531_CR4","first-page":"328","volume":"241","author":"LG Latimer","year":"1987","unstructured":"Latimer LG, Duffy P, Kalivas PW (1987) Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area. J Pharmacol Exp Ther 241:328\u2013337","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02253531_CR5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0014-2999(91)90715-3","volume":"203","author":"L-Y Liu-Chen","year":"1991","unstructured":"Liu-Chen L-Y, Li S, Wheeler-Aceto H, Cowan A (1991) Effects of intracerebroventricular \u03b2-funaltrexamine on \u03bc and \u03b4 opioid receptors in the rat: dichotomy between binding and antinociception. Eur J Pharmacol 203:195\u2013202","journal-title":"Eur J Pharmacol"},{"key":"BF02253531_CR6","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1523\/JNEUROSCI.11-06-01565.1991","volume":"11","author":"R Longoni","year":"1991","unstructured":"Longoni R, Spina L, Mulas A, Carboni E, Garau L, Melchiorri P, Di Chiara G (1991) (D-Ala2) deltorphin II: D1-dependent stereotypes and stimulation of dopamine release in the nucleus accumbens. J Neurosci 11:1565\u20131576","journal-title":"J Neurosci"},{"key":"BF02253531_CR7","first-page":"308","volume":"11","author":"A Mansour","year":"1988","unstructured":"Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ (1988) Anatomy of CNS opioid receptors. TINS 11:308\u2013314","journal-title":"TINS"},{"key":"BF02253531_CR8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0014-2999(92)90319-Y","volume":"219","author":"K Menkens","year":"1992","unstructured":"Menkens K, Bilsky EJ, Wild KD, Portoghese PS, Reid LD, Porreca F (1992) Cocaine place preference is blocked by the \u03b4-opioid receptor antagonist, naltrindole. Eur J Pharmacol 219:345\u2013346","journal-title":"Eur J Pharmacol"},{"key":"BF02253531_CR9","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/0014-2999(90)93886-U","volume":"183","author":"M Narita","year":"1990","unstructured":"Narita M, Suzuki T, Misawa M, Nagase H (1990) Effects of kappa opioids on the morphine-induced pharmacological actions. Eur J Pharmacol 183:2328","journal-title":"Eur J Pharmacol"},{"key":"BF02253531_CR10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0024-3205(93)90153-T","volume":"52","author":"M Narita","year":"1993","unstructured":"Narita M, Suzuki T, Funada M, Misawa M, Nagase H (1993) Blockade of the morphine-induced increase in turnover of dopamine on the mesolimbic dopaminergic system by \u03ba-opioid receptor activation in mice. Life Sci 52:397\u2013404","journal-title":"Life Sci"},{"key":"BF02253531_CR11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0014-2999(88)90502-X","volume":"146","author":"PS Portoghese","year":"1988","unstructured":"Portoghese PS, Sultana M, Takemori AE (1988) Naltrindole, a highly selective and potent non-peptide \u03b4 opioid receptor antagonist. Eur J Pharmacol 146:185\u2013186","journal-title":"Eur J Pharmacol"},{"key":"BF02253531_CR12","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1021\/jm00168a028","volume":"33","author":"PS Portoghese","year":"1990","unstructured":"Portoghese PS, Sultana M, Takemori AE (1990) Design of peptidomimetic \u03b4 opioid antagonists using the message-address concept. J Med Chem 33:1714\u20131720","journal-title":"J Med Chem"},{"key":"BF02253531_CR13","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1021\/jm00109a027","volume":"34","author":"PS Portoghese","year":"1991","unstructured":"Portoghese PS, Nagase H, MaloneyHuss KE, Lin C-E, Takemori AE (1991) Role of spacer and address components in peptidomimetic \u03b4 opioid receptor antagonists related to naltrindole. J Med Chem 34:1715\u20131720","journal-title":"J Med Chem"},{"key":"BF02253531_CR14","first-page":"405","volume":"247","author":"RB Rothman","year":"1988","unstructured":"Rothman RB, Long JB, Bykov V, Jacobson AE, Rice KC, Holaday JW (1988) \u03b2-FNA binds irreversibly to opiate receptor complex: in vivo and vitro evidence. J Pharmacol Exp Ther 247:405\u2013416","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02253531_CR15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(89)90038-1","volume":"159","author":"P Sanchez-Blazquez","year":"1989","unstructured":"Sanchez-Blazquez P, Garzon J (1989) Evaluation of \u03b4 receptor mediation of supraspinal opioid analgesia by in vivo protection against the \u03b2-funaltrexamine antagonist effect. Eur J Pharmacol 159:9\u201323","journal-title":"Eur J Pharmacol"},{"key":"BF02253531_CR16","first-page":"676","volume":"257","author":"M Sofuoglu","year":"1991","unstructured":"Sofuoglu M, Portoghese PS, Takemori AE (1991) Differential antiagonism of delta opioid agonists by naltrindole (NTI) and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes. J Pharmacol Exp Ther 257:676\u2013680","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02253531_CR17","first-page":"377","volume":"80","author":"SJ Ward","year":"1982","unstructured":"Ward SJ, Portoghese PS, Takemori AE (1982) Pharmacological profiles of \u03b2-funaltrexamine (\u03b2-FNA) and \u03b2-chlornaltrexamine (\u03b2-CNA) on the mouse vas deferens preparation. J Pharmacol Exp Ther 80:377\u2013384","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02253531.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02253531\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02253531","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T14:52:25Z","timestamp":1558018345000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02253531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,7]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1993,7]]}},"alternative-id":["BF02253531"],"URL":"https:\/\/doi.org\/10.1007\/bf02253531","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,7]]}}}